Why Albireo Pharma Shares Moving Higher Today?
September 22, 11:27 AM
Albireo Pharma Inc (NASDAQ:ALBO) entered into a royalty monetization agreement with Sagard Healthcare Partners for $115 million in return for a…
Novo Nordisk’s Experimental Diabetes Treatment Achieves Better Blood Sugar Targets Than Insulin Degludec
September 22, 11:23 AM
Novo Nordisk A/S (NYSE:NVO) presented new data from the phase 3a ONWARDS 2 trial of insulin icodec in type 2 diabetes…
Henry Ford Health First In Michigan To Offer Multi-Cancer Early Detection Blood Test
September 22, 11:03 AM
First-of-its-kind Galleri® Multi-Cancer Early Detection blood test can screen for multiple cancers through a single blood draw.
DETROIT and MENLO PARK, Calif., Sept. 22, 2022 /PRNewswire/
Invitae Released A New Study In JAMA Network Open Clinical Practice Guidelines Recommend Genetic Testing Of All Patients With Breast Cancer
September 22, 11:02 AM
Invitae study reports universal genetic testing improves outcomes for patients with breast cancer –
SAN FRANCISCO, Sept. 22, 2022 /PRNewswire/ -- Invitae (NYSE:NVTA), a leading
BARDA Exercises First Contract Option With Marinus Pharma For Its Epilepsy Candidate
September 22, 10:55 AM
Marinus Pharmaceuticals Inc (NASDAQ:MRNS) announced that the Biomedical Advanced Research and Development Authority (BARDA) exercised its first contract option,…
Pfizer To Supply 6M COVID-19 Therapy Courses To Low Income Countries
September 22, 10:37 AM
Pfizer Inc (NYSE:PFE) would supply up to 6 million courses of its COVID-19 antiviral treatment to NGO Global Fund for low-…
Better Therapeutics Seeks FDA Approval For First Digital Therapeutic For Type 2 Diabetes
September 22, 9:44 AM
Better Therapeutics Inc (NASDAQ:BTTX) has submitted a de novo classification request to the FDA seeking approval for BT-001 digital therapeutic designed to…
FDA Approves Lilly’s Retevmo, the First and Only RET Inhibitor For Solid Tumor Indications
September 22, 8:47 AM
The FDA has approved Eli Lilly And Co’s (NYSE:LLY) Retevmo (selpercatinib, 40 mg & 80 mg capsules) for solid tumors. The…
Why Are Plus Therapeutics Shares Gaining Today?
September 22, 8:35 AM
Plus Therapeutics Inc (NASDAQ:PSTV) has finalized and signed a grant contract with the Cancer Prevention & Research Institute of Texas (CPRIT)…